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1 Introduction
Prolonged treatment with j3-sympathomimetics for
Inhibition of premature labor has been accepted
worldwide for a couple of years. The initial use of
drugs like isoxyprimchloride with a mixed ß\ and
02 effect has gradually been exchanged by more
selective j32 stimulatory compounds like ritodrine,
salbutamol and terbutaline since both experimental
and clinical results have demonstrated their super-
iority in this context. So far interest has mainly
been focused upon 1) the Prolongation of preg-
nancy that can be obtained [7, 11] 2) metabolic
influences on the mother and fetus [1,2] and 3)
acute influence on fetal heart rate [3].
In a recent study by FREYSZ et dl. [4] a long-
term evaluation of infants who received j3-sym-
pathomimetic drugs while in utero was reported in
a case material of 42 children. In the present study
the efficacy of three various j3-sympathomimetic
drugs on premature labor was compared and the
children followed up to 18 months after delivery.
2 Material and methods
The material includes patients with premature
labor attending the Department of Obstetrics
and Gynaecology, Sahlgren's University Hospital
between August 73 to January 76. Selections of
patients were made according to the following
criteria:
a) length of gestation 25 to 35 weeks
b) uterine contractions with a frequency of at least
10 per h, registered by use of a cardiotocograph
(CTG)
c) cervix not dilated to more than 4 cm
d) no obvious signs of ruptured membranes
According to these criteria 79 of a total number of
152 with preterm labor were included in this
study. The patients were divided into three groups
treated with either isoxyprine, ritodrine or ter-
butaline. The choice of treatment for each patient
was unselected.
Careful anamnestic obstetric recordings were made
with special reference to earlier premature labor
and abortions (see Results). All patients were super-
vised for minimum 24 h in the delivery ward, after
which time they were hospitalized for various
periods of time depending upon the outcome of
treatment. CTG registration was äs a rule performed
continously during the initial treatment followed
by daily registrations for 30 minutes.
At delivery APGAR score was registered after one
and five minutes. All children with birth-weights
below 2 500 g and/or a reduced APGAR score at
5 minutes (< 7) were supervised and treated in a
well-equipped neonatal unit. A special follow-up
Programme was performed on these children by
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one of the authors, 5, 10 and 18 months after
delivery.
2. l Schedules of treatment
1: Isoxyprine (Duvadilan® FERROSAN Ltd,
Sweden). Intravenous Infusion: 90 mg isoxypyrine
to l 000 ml Invertos (Aco, Ltd, Sweden). Infusion
rate 0.05-0.20 mg/min. After Interruption of
premature labour äs judged from the CTG regi-
stration for 15-48 h, treatment withtablets (10 mg
X 4-8 daily) was continued for varying periods of
time, not exceeding the 35th week of gestation.
2: Ritodrine (PHILIPS-ÜUPHAR,Netherlands). Intra-
venous infusion: 100 mg Ritodrine to 500 ml 5.5 %
glucose. Infusion rate 100—400 /zg/min for 12 to
48 h. After Interruption of premature labour treat-
ment with tablets (10 mg X 4-8) was continued in
a similar way äs for isoxyprine.
3: Terbutaline (Bricanyl®, DRACO, Sweden).
Intravenous infusion: 5 mg terbutaline to l 000 ml
5.5 % glucose. Infusion rate 2.5-15 Mg/min for 15
to 48 h. After Interruption of premature labour
treatment was continued by oral administration of
terbutaline (5 mg X 3).
After delivery each child was scored according to
APGAR, and when indicated (low birth weight or
APGAR < 7 at 5 min) transferred to the intensive
neonatal unit. Between 4 to 7 days after delivery
each newborn was carefully checked by a pedia-
trician. The children were thereafter scheduled for
a special check up at 5, 10 and 18 months. The
aim of the rigorous pediatric follow-up was prim-
arily to reveal intrauterine rgrowth development,
perinatäl asphyctic syndrome, neonatal respiratory
distress (RDS) and mortality. Secondly post-partum
growth and psychomotoric development were
evaluated.
3 Results
Tab. I summarizes data concerning maternal age,
earlier pregnancies, spontaneous abortions and
premature delivery, and the gestational age when
premature labour started. The groups did not differ
significäntly in these parameters.
The meän gain in weeks for the three /J-mimetics
was for Isoxyprine 2.48, Ritodrine 4.45 and for
Bricariyl 5.00. If the material for the respective
groups is divided in failures (Prolongation less than
7 days) and successful cases (Prolongation > 7
days) a tendency towards a higher success rate
with terbutaline compared to the two others was
found (Tab. II).
The choice of method for delivery and the con-
dition of the newborn children äs judged from
birth-weights, APGAR scores and the presence of
respiratory disturbances for the various groups are
summarized in Tab. III. An evaluation concerning
the weight äs related to gestational age was per-
formed comparing actual birth-weight with the
expected weight at delivery. No statistical deviation
Tab. I. Obstetrical data of the total number of patients treated for premature labour.

















weeks 26-30 n = 8
weeks 31-35 n = 17
mean31.96 ±0.80
weeks 26-29 n = 7,
weeks 31-35 n^ 22
mean 31.62 ± 0.60
weeks 26-30 n - 14
weeks 31-35 n = 11
mean 30.16 ± 0.67
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Tab. II. Induced Prolongation of pregnancy after treatment with three /3-mimetics.
Gain in days from
Start of therapy to delivery
Isoxyprine
< 7 days > l days
Ritodrine
< 7 days > 7 days
Terbutaline



























Tab. III. Methods of delivery. Apgar scores and lung complications during neonatal life.
Gain in days from start of
therapy to delivery
Isoxyprine
< 7 days > 7 days
Ritodrine
< 7 days > 7 days
Terbutaline
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No of children with APGAR
<75 '
Respiratory disturbances










was, however, found although 5 children in the
total material were smaller than 2 SD from the
mean.
At 18 months of age the mean weights of the sur-
viving children in the various groups did not differ
from the normal weight at this age. Tab. IV illu-
strates the mortality in the various groups up to
l year of age.
There is a considerably high mortality rate in the
"failure groups". There is, however, no statistical
difference between any of the groups in this respect.
Two children, one in the isoxyprine and one in the
terbutaline successful groups, died 4 and 11 months
post partum. In both these cases neither autopsy
nor bacterial cultures could diagnose the reasons
for this outcome. Among the surviving children
(Tab. V) two had signs of psychomotoric disturb-
ances at 18 months of age, both belonging to the
ritodrine failure group. One child was born after
46 h of ritodrine treatment in gestational week 32
demonstrating both intra- and extrauterine hypoxia
signs, complicated by an intracranial haemorrhage
J. Perinat. Med. 8(1980)
22 Karlsson et al., Comparison of betamimetics
Tab. IV. Mortality rates during the first year of life after treatment of mothers with /3-mimetics.
Isoxyprine
< 7 days > l days
Ritodrine
< 7 days > 7 days
Terbutaline
• r
< 7 days > 7 days
Total number of
delivered children
14* 12 13" 17




Mortality betvveen 7 days







and a prolonged period of hyperbilirubinaemia
(Tab. V). The other child, born in week 283 devel-
oped a severe RDS and later on had signs of intra-
cranial haemorrhage.
In neither of the groups a retarded growth rate was
found at 18 months of age (Tab. V).
4 Discussion
In the present study three different j3-mimetics
were compared primarily with reference to their
efficacy to prolong pregnancy (see Tab. II). The
more selective j32-sympathomimetics ritodrine and
terbutaline showed almost identical results while
isoxuprine turned out to be less potent. The failure
rate in the three various groups were, however, very
similar indicating that our criteria for selection of
patients includes a comparatively large group which
is beyond possibilities for therapy. No placebo
group was included in this study mainly due to
ethical reasons but in a study by INGEMARSSON
[5] 15 patients on terbutaline were compared to
a double-blind placebo controlled group in the
28-36 weeks of gestation.In the terbutaline-treated
group premature labour was arrested in 80 % of
the patients while the corresponding value for the
control group was 20 %. It must, however, be
pointed out that the majority of cases in INGE-
MARSSON'S study were treated in a later stage of
pregnancy than in our study. Side-effects like
tachycardia, tremor and vomiting in the present
study were comparable in the three groups when
the different agents were administered äs de-
scribed under Materials and Methods. In INGE-
MARSSON's study [5] all children survived while
the present study demonstrates a high mortality
(18.5 %) especially in the isoxyprine group (see
Tab. IV). In a recently published multicentre
study from the United States [6] the neonatal
mortality after ritodrine treatment was 5 %. The
mortality in the present study is divided into neo-
natal mortality (12.4 %) and mortality within the
Tab. V. Pediatric follow-up of children to mothers treated with 0-mimetics.
Gain in days from start of
treatment to delivery
Isoxyprine
< 7 days > 7 days
Ritodrine
< 7 days > 7 days
Mean weight (kg) 11.4 11.6 12.0 11.8
Terbutaline
< 7 days > days









*) One child with a moderate Hearing defect
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first year of life (6. l %). Of importance to point out,
though, is the fact that the children included in
the group "neonatal mortality" in the present
material were all very premature at delivery (mean
gestational age 28 weeks and mean body weight
990 ± 71 g, see Tab. I). However, this points to
the importance of following the children of mothers
who have been treated with 0-mimetics beyond
the neonatal period. In the present material 5
children out of 15 died much beyond the neonatal
period and in two of these cases no obvious reasons
for death were found.
It would have been of interest to compare the
mortality in a matched untreated control group.
However, since the incidence of earlier spontaneous
abortions and earlier preterm labor in the case
material of this study is approximately 50 % it is
already a selected material which cannot be
compared to unselected groups of women who
deliver preterm.
Low APGAR scores and respiratoiy disturbances
were frequent in all three "failure" groups and
showed no significant differences (Tab. III). These
findings agree well with the expected incidence of
disturbances at this age of gestation and do not
seem to be influenced by 0-sympathomimetic
drugs. In the "success" groups APGAR scores and
birth weights do not differ significantly from
normal deliveries in the corresponding weeks of
gestation. The possible long-term effects on chil-
dren born by mothers who had been treated with
j3-sympathomimetic drugs were also investigated
by repeated examinations of the children up to
18 months. No significant differences in body
weights compared to corresponding controls were
found. In 2 cases belonging to the ritodrine
"failure" group severe hemiparesis remained at 18
months of age. The first case was born in the 28th
week of gestation after 36 h of iv ritodrine treat-
ment. Immediately upon birth both a marked RDS
and an intracranial haemorrhage were diagnosed.
In the second case born in week 33 with a duration
of ritodrine treatment of 48 h both intra- and ex-
trauterine hypoxia were registered. The neonatal
period was later complicated by hyperbilirubi-
naemia and intracranial haemorrhage.The long-term
evaluation thus includes two children with severe
cerebral paresis and additional 5 children dying
beyond the neonatal period, two of them in un-
suspected sudden death. This points to the need of
extended supervision of this group of high risk
patients a fact which has also recently been pointed
out in a similar study performed by FREYZ et al
[4]. In conclusion or data are in accordance with
numerous other reports demonstrating that j3-sym-
pathomimetics are able to prevent preterm labor
and that the more selective j32 drugs are the most
potent in this respect. It must, however, be strongly
pointed out that the possible negative long-term
effects on children of treated mothers are still un-
known and the present material cannot exclude
such risks. As early äs in 1959 RONA et al [8]
reported that application to rats of isoproteronol
caused "infarct-like lesions" in the myocard.
WEIDINGER et al [10] recently reported that
fenoterol added to human fetal heart muscle in
culture caused degeneration that could be counter-
acted by addition of the calcium antagonist vera-
panil. No convincing signs of myocardial necrosis
were, however, found in the two cases of sudden
death in the present material. Further studies are,
however, urgently needed specially focused upon
the possible long-term effects on the heart muscle
of diseased children.
Summaiy
During the past five years Inhibition of preterm labor
by use of 0-sympathomimetics has been common practice.
The initial use of compounds with mixed 0, and 02 effect
has gradually been replaced by more selective 02 com-
pounds. Hitherto the interest has been mainly focused
upon the elicited Prolongation ofpregnancy,possible fetal
or maternalmetabolic disturbances and the acute influence
on fetal heart rate. Only few reports mention the possibility
of long-term effects in children of treated mothers.
In the present study the efficacy of three different 0-sym-
pathomimetics on premature labour was studied and the
children followed for 18 months after delivery.
Seventy-nine patients were treated with either isoxyprine
(n = 25), ritodrine (n = 29) or terbutaline (n = 25).
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Following criteria were demanded for entering the study:
1) length of gestation 25 or 35 weeks, 2) uterine con-
tractions of at least 10 per hour (CTG registered), 3)
cervix not dilated more than 4 cm and 4) no rupture of
the membranes. In each group the patients were treated
primarily with an intravenous Infusion followed by oral
administration of the respective compound. The treat-
ment was considered successful if Prolongation of preg-
nancy exceeded 7 days. The "failure" group (pregnancy
Prolongation < 7 days) was somewhat smaller in the
terbutaline group compared to both the isoxyprine and
the ritodrine groups.
The Prolongation of pregnancy was shorter for isoxuprine
(x 17.4 days) compared to ritodrine (x 31.2 days) and
terbutaline (x 35.0 days). The children were carefully
supervised by pediatricians during the first week of life
and thereafter scheduled for a special check up at 5, 10
and 18 months after delivery.
A tendency towards a higher degree of 'light for gestatio-
nal age" in all three groups were found, but this was not
statistically significant. At 18 months of age the sur-
viving children did not differ significantly from the normal
Keywords: ß-sympathomimetics, long term effects fetus: mortality-morbidity, premature labour.
weight at this age, thus no retarded growth rate at 18
months of age was found. Ten children (12 %) died
during the neonatal period, while 5 children (6 %) died
beyond the neonatal period,' tWo of them unexpectedly
and suddenly.
Two children had signs of psychomotoric disturbances at
18 months of age, both belonging to the group treated
with ritodrine. The present study confirms earlier reports
demonstrating that more selective ß2 compounds are
mosf pbte'nt" in irihibiting premature labour. From the
long-term evaluation of children of treated mothers a
remarkably high incidence of complications occurred
(7.8 %). In this connection it is worth-while to keep in
mind the findings of myocardial necrosis reported after
isoproteronol treatment to rats and the reports concerning
in vitro degeneration in human fetal heart after fenoterol
treatment.
It may thus be concluded that treatment with 0-sym-
pathomimetics should be restricted to carefully selected
groups since long-term adverse effects on children of
treated mothers at present cannot be excluded.
Zusammenfassung
Die Beeinflussung der drohenden Frühgeburt, der Über-
lebensrate und der kindlichen Entwicklung durch Beta-
mini et ik a
Seit etwa 5 Jahren werden /3-Sympathoathomimetika
zur Abwendung einer vorzeitigen Geburt in großem Maße
eingesetzt. Die anfänglich verwendeten Verbindungen mit
Wirkung auf ß^ und ß2-Rezeptoren wurden nach und nach
durch Sypmathomimetika mit selektivem ß2 -Effekt er-
setzt. Bisher richtete sich das Interesse in erster Linie
darauf, wie lange der Geburtszeitpunkt tatsächlich hinaus-
geschoben werden konnte und ob fetale oder mütterliche
Stoffwechselstörungen als Folgen der Behandlung auf-
traten. Auch die akute Beeinflussung der fetalen Herz-
frequenz wurde intensiv beobachtet. Die Möglichkeit
eines Langzeiteffektes auf Kinder von behandelten Müttern
wurde bislang jedoch nur in wenigen Studien diskutiert.
Die vorliegende Arbeit untersucht die Wirksamkeit von 3
verschiedenen /3-Sympathomimetika hinsichtlich einer
Schwangerschaftsverlängerung bei drohender Frühgeburt
sowie die kindliche Entwicklung während der ersten 18
Monate.
Insgesamt wurden 79 Patientinnen entweder mit Isoxyprin
(n=25) oder mit Ritodrin (n=29) oder mit Terbutalin
(n=25) behandelt. Es mußten folgende Kriterien erfüllt
sein:
1) Dauer der Schwangerschaft entweder 25 oder 35
Wochen
2) mindestents 10 Kontraktionen pro Stunde (nach CTG-
Aufzeichnung)
3) Muttermund nicht mehr als 4 cm geöffnet
4) kein Blasensprung
In jeder Gruppe wurde den Patientinnen anfangs die ent-
sprechende Verbindung i.v. infundiert, anschließend oral
verabreicht. Die Behandlung galt als erfolgreich, wenn die
Schwangerschaft um mindestens 7 Tage verlängert werden
konnte. Wir stellten fest, daß in der Terbutalin-Gruppe der
Anteil der 'erfolglos' Behandelten (d.h. Schwangerschafts-
verlängerung < 7 Tage) verglichen mit den beiden anderen
Gruppen am geringsten war.
Mit Isoxyprin wurde im Mittel der geringste Behandlungs-
erfolg erreicht (x=174 Jage), gefolgt von Ritodrin (x=
31.2 Tage) und Terbutalin (x=35.0 Tage). Während der
ersten 7 Lebenstage wurden die Kinder von Pädiatern
sorgfältig beobachtet, und im Alter von 5, 10 und 18
Monaten wurden sie einer speziellen Nachuntersuchung
unterzogen.
Wir stellten in allen 3 Gruppen die Tendenz fest, daß die
Kinder bei der Geburt für das entsprechende Schwanger-
schaftsalter zu wenig Gewicht hatten, konnten die Unter-
schiede aber nicht statistisch sicherri.Mit 18 Monaten
hatten die Kinder ein altersentsprechendes Gewicht und
zeigten damit ein normales Wachstum. Zehn Kinder
(12 %) starben in der Neonatalperiode; 5 starben erst
nach der neonatalen Phase, wovon bei zweien der Tod
unerwartet und plötzlich einsetzte. Bei 2 Kindern be-
obachtete man im Alter von 18 Monaten psychomoto-
rische Störungen; beide Kinder kamen aus der Ritodrin-
behandelten Gruppe.
Die vorliegende Studie bestätigt die Ergebnisse früherer
Arbeiten dahingehend, daß Verbindungen mit einem
stärkeren 02-Effekt den Geburtszeitpunkt länger hinaus-
zögern und damit wirksamer sind. Auf der anderen
Seite jedoch ergab die Langzeit-Untersuchung der Kinder
eine bemerkenswert hohe Komplikationsrate (7-8 %).
In diesem Zusammenhang möchten wir an tierexperimen-
telle Untersuchungen erinnern, in denen nach Isoprote-
ronol-Behandlung bei Ratten myokardiale Nekrosen
nachgewiesen werden konnten. Darüberhinaus gibt es
Arbeiten, die in vitro beobachtete Degenerationsprozesse
am menschlichen fetalen Herzen nach Fenoterol-Behand-
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lung beschreiben. Unsere Schlußfolgerung lautet daher:
die Behandlung mit 0-Sympathomimetika sollte aus-
schließlich auf sorgfältig ausgewählte Patientengruppen
beschränkt werden, weil nachteilige Langzeiteffekte bei
Kindern behandelter Mütter gegenwärtig nicht ausge-
schlossen werden können.
Schlüsselwörter: 0-Sympathomimetika, Frühgeburt, Langzeiteffekte: Mortalität, Morbidität.
Resume
Compaiaison des divers betamimetiques sur le travail
premature, la survie et le developpement de l'enfant
L'inhibition du travail premature par les 0-sympathomi-
metiques ont ete d'un usage courant ces 5 dernieres
annees. L'emploi initial de composes avec effet combine
de j3t et 02 a fait progressivement place a l'application
plus differenciee des composes ß2. Jusqu'ici l'interet s'est
surtout concentre sur la Prolongation explicite de la
grossesse, les troubles metaboliques foetaux ou maternels
possibles et l'influence marquee sur la frequence cardiaque
foetale. Seuls quelques rapports mentionnent l'eventualite
d'effets a long terme chez les enfants de meres ayant subi
le traitement.
L'article present porte sur l'etude de l'efficacite de trois
0-sympathomimetiques sur le travail premature et
lobservation des enfants pendant les 18 mois suivant
laccouchement' 79 patients ont ete traites soit a
l.isoxyprine (n = 25), a la ritodrine (n = 29) ou a la
terbutaline (n = 25).
Les conditions requises pour faire l'objet de l'etude ont
ete: 1) Une duree de gestation de 25 ä 35 semaines, 2) des
contractions uterines de 10 au moins par heure (CTG
enregistre), 3) une dilatation du col de Fut6rus ne de-
passant pas 4 cm et 4) aucune rupture des membranes.
Dans chaque groupe, les patientes ont regu en premier
une infusion intraveineuse suivie de l'administration du
compose respectif. Le traitement a ete considere comme
reussi lorsque la Prolongation de la grossesse a depasse
7 jours. Le groupe d'«echec» (Prolongation de la
grossesse < 7 jours) a ete un peu plus reduit dans le
groupe soigne a la terbutaline que chez les deux autres
groupes soignes a l'isoxyprine et a la ritodrine.
La Prolongation de la grossesse a ete plus courte dans
les cas d'isoxyprine (x- 17,4 jours) que dans ceux de
ritodrine (x 31,2 jours) ou de terbutaline (x 35,0 jours).
Les enfants ont ete suivis attentivement par les pediätres
durant la premiere semaine, puis examines a 5, 10 et 18
mois apres l'accouchement.
On a pu observer dans les 3 groupes une tendance vers
un degre plus eleve de <,light for gestational age;, mais
sans signification statistique. A 18 mois, on n'a releve
aucune difference significative de poids entre les enfants
normaux et ceux ayant survecu et, par consequent, aucun
taux de croissance retardee. Dix enfants (12 %) sont
morts durant la periode neonatale, 5 (6 %) au-dela de
cette periode dont 2 d'une mort subite et inattendue.
Deux enfants ont manifeste des troubles psychomoteurs
a Tage de 18 mois, tous 2 appartenant au groupe soigne
a la ritodrine. L'etude presente confirme les rapports
anterieurs ayant demontre que les composes ß2 plus
selectifs sont davantage capables d'inhiber le travail
prematuree. Une evaluation a long terme des enfants de
meres traitees a montre une incidence remarquablement
elevee de complications (7.8%). Cette observation incite
a porter son attention sur les resultats de necrose myo-
cardiale enregistree a la suite d'un traitement a l'isopro-
teronol sur les rats, et sur les rapports concernant la
degenerescence in vitro du coeur foetal humain apres
un traitement au fenoterol.
En conclusion, on peut conseiller de restreindre le
traitement aux /J-sympathomimetiques a des groupes
soigneusement selectionnes, etant donne Timpossibilite
actuelle d'exclure absolument des effets negatifs a long
terme sur les enfants de meres ayant subi ce traitement.
Mots-cles: j3-sympathomimetiques, effets a long terme sur le foetus: mortalite-morbidite, travail premature.
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